Protocols
1 protocol(s) meet the specified criteria
Drug: Navitoclax
Protocol No.TitleStatus
NCI9903A Phase 1B Study of AZD9291 in Combination with Navitoclax in EGFR-mutant Non-Small Cell Lung Cancer Following Resistance to Initial EGFR Kinase InhibitorOpen